Effects of Canagliflozin on microbiota and glycometabolism, kidney function of patients with diabetic nephropathy
Not Applicable
Completed
- Conditions
- diabetic nephropathy
- Registration Number
- JPRN-UMIN000020710
- Lead Sponsor
- Keio University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
1.patiens whose eGFR declined more than 25% during the observation period 2.patients with fasting blood glucose higher than 250mg/dl 3.patients who has been on dialysis or who went through renal transplantation 4.patients with type 1 diabetes or secondary diabetes 5.patients who has taken other investigational drugs within 3months of the beginning of this study 6.patients who fall under contraindication of Canagliflozin 7.patients whom the doctor decided unsuitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the microbiome of patients with diabetic nephropaty
- Secondary Outcome Measures
Name Time Method